F Wolfe

Summary

Affiliation: National Data Bank for Rheumatic Diseases
Country: USA

Publications

  1. doi Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, Kansas, United States of America
    PLoS ONE 9:e88740. 2014
  2. pmc The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort
    Mary Ann Fitzcharles
    Division of Rheumatology, McGill University, Montreal, Canada
    BMC Musculoskelet Disord 13:179. 2012
  3. pmc The German fibromyalgia consumer reports - a cross-sectional survey
    Winfried Häuser
    Department Internal Medicine I, Klinikum Saarbrücken, Saarbrücken D 66119, Germany
    BMC Musculoskelet Disord 13:74. 2012
  4. doi Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS, USA
    Arthritis Care Res (Hoboken) 65:777-85. 2013
  5. doi Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia
    F Wolfe
    Rheumatology, National Data Bank for Rheumatic Diseases, Wichita, Kansas, USA
    Eur J Pain 17:581-6. 2013
  6. doi Effect of body mass index on mortality and clinical status in rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS 67214, USA
    Arthritis Care Res (Hoboken) 64:1471-9. 2012
  7. pmc The determination and measurement of functional disability in rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases Arthritis Research Center Foundation and University of Kansas School of Medicine, Wichita, Kansas, USA
    Arthritis Res 4:S11-5. 2002
  8. pmc Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
    Teresa A Simon
    Global Health Economics and Outcomes Research, Bristol Myers Squibb, Route 206 and Province Line Roads, Lawrenceville, NJ 08540, USA
    Arthritis Res Ther 12:R67. 2010
  9. ncbi The Short Arthritis Assessment Scale: a brief assessment questionnaire for rapid evaluation of arthritis severity in research and clinical practice
    Frederick Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, 1025 N Emporia, Wichita, KS 67214, USA
    J Rheumatol 31:2472-9. 2004
  10. ncbi Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    Arthritis Rheum 54:628-34. 2006

Collaborators

Detail Information

Publications120 found, 100 shown here

  1. doi Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, Kansas, United States of America
    PLoS ONE 9:e88740. 2014
    ....
  2. pmc The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort
    Mary Ann Fitzcharles
    Division of Rheumatology, McGill University, Montreal, Canada
    BMC Musculoskelet Disord 13:179. 2012
    ..The reliability and validity of the translated French version of the FSDC was evaluated...
  3. pmc The German fibromyalgia consumer reports - a cross-sectional survey
    Winfried Häuser
    Department Internal Medicine I, Klinikum Saarbrücken, Saarbrücken D 66119, Germany
    BMC Musculoskelet Disord 13:74. 2012
    ..Consumer surveys provide information on effectiveness and side effects of medical interventions in routine clinical care. A report of fibromyalgia syndrome (FMS) consumers has not been carried out in Europe...
  4. doi Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS, USA
    Arthritis Care Res (Hoboken) 65:777-85. 2013
    ..To evaluate fibromyalgia in the general population with emphasis on prevalence, dimensionality, and somatic symptom severity...
  5. doi Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia
    F Wolfe
    Rheumatology, National Data Bank for Rheumatic Diseases, Wichita, Kansas, USA
    Eur J Pain 17:581-6. 2013
    ..We describe the changing pattern of analgesic and new central acting drug (NCAD) use (pregabalin, duloxetine, milnacipran) in fibromyalgia and measure NCAD effectiveness in clinical practice...
  6. doi Effect of body mass index on mortality and clinical status in rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS 67214, USA
    Arthritis Care Res (Hoboken) 64:1471-9. 2012
    ..To study the relative risk (RR) of all-cause and cause-specific mortality in rheumatoid arthritis (RA) associated with body mass index (BMI), and to quantify the clinical and outcome consequences of abnormal BMI...
  7. pmc The determination and measurement of functional disability in rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases Arthritis Research Center Foundation and University of Kansas School of Medicine, Wichita, Kansas, USA
    Arthritis Res 4:S11-5. 2002
    ..Using the Health Assessment Questionnaire as the main functional outcome measure in rheumatoid arthritis, we propose and discuss several methods for determining disability, and describe the implications of altering the disability course...
  8. pmc Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
    Teresa A Simon
    Global Health Economics and Outcomes Research, Bristol Myers Squibb, Route 206 and Province Line Roads, Lawrenceville, NJ 08540, USA
    Arthritis Res Ther 12:R67. 2010
    ....
  9. ncbi The Short Arthritis Assessment Scale: a brief assessment questionnaire for rapid evaluation of arthritis severity in research and clinical practice
    Frederick Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, 1025 N Emporia, Wichita, KS 67214, USA
    J Rheumatol 31:2472-9. 2004
    ..To develop a short, 4-item arthritis severity questionnaire that is simple to score, clinically useful and meaningful, and suitable for use in primary care, where osteoarthritis (OA) is the primary prevalent arthritis illness...
  10. ncbi Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    Arthritis Rheum 54:628-34. 2006
    ..This study was undertaken to determine the rate and predictors of hospitalization for pneumonia and the extent to which specific RA treatments increase pneumonia risk...
  11. ncbi Anemia and renal function in patients with rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, 67214, USA
    J Rheumatol 33:1516-22. 2006
    ..Despite recognition that anemia is common in RA and that renal function may be impaired and affect hemoglobin levels, there are almost no quantitative comparative data regarding the prevalence of anemia or decreased renal function in RA...
  12. ncbi The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, 1035 N Emporia, Wichita, KS 67214, USA
    J Rheumatol 33:2291-9. 2006
    ....
  13. ncbi Data collection, maintenance, and analysis for rheumatic disease research
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, 1035 North Emporia, Suite 230, Wichita, KS 67214, USA
    Rheum Dis Clin North Am 30:753-68, vi. 2004
    ..This article describes concepts, methods, and problems in database construction and analysis based on the experience of the US National Data Bank for Rheumatic Diseases...
  14. pmc Why results of clinical trials and observational studies of antitumour necrosis factor (anti-TNF) therapy differ: methodological and interpretive issues
    F Wolfe
    University of Kansas, School of Medicine, Arthritis Research Center Foundation, 1035 N Emporia, Suite 230, Wichita, KS 67214, USA
    Ann Rheum Dis 63:ii13-ii17. 2004
    ..Results of randomised clinical trials (RCTs) appear to differ from results of observational studies. This paper explores differences in methodology, interpretation and presentation of results that elucidate these differences...
  15. ncbi Can severity be predicted by treatment variables in rheumatoid arthritis administrative data bases?
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 33:1952-6. 2006
    ..We examined whether treatment variables could predict RA severity...
  16. ncbi Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scales
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 33:1942-51. 2006
    ..SD has taken on new importance with the observation that etanercept and infliximab reduce daytime sleepiness, and patient groups indicate that sleep is an important issue...
  17. ncbi Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders
    F Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, 1035 N Emporia, Suite 230 Wichita, KS 67214, USA
    Rheumatology (Oxford) 45:1370-5. 2006
    ..We examined its rate and predictors in rheumatoid arthritis (RA) and non-inflammatory musculoskeletal (MSK) disorders to determine if HZ was increased in RA and whether treatment contributed to the risk of HZ...
  18. ncbi Jaw pain: its prevalence and meaning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 32:2421-8. 2005
    ..We investigated the prevalence and correlates of jaw pain, and whether jaw pain is increased in RA, where intrinsic articular disease can be noted radiographically, or is a manifestation of a generalized pain problem...
  19. ncbi A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II)
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 32:2410-5. 2005
    ..To develop and validate a composite patient self-report disease activity scale for use in clinical practice and in observational studies and clinical trials...
  20. ncbi Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis
    Frederick Wolfe
    Arthritis Research Center Foundation and the University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 32:583-9. 2005
    ..To define RID, we compared mean and/or least desirable clinical states with best and/or most desirable states...
  21. ncbi Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis
    Frederick Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, KS 67214, USA
    J Rheumatol 32:1261-6. 2005
    ....
  22. ncbi Household income and earnings losses among 6,396 persons with rheumatoid arthritis
    Frederick Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, KS 67214, USA
    J Rheumatol 32:1875-83. 2005
    ..We describe methods for obtaining earnings and household income losses that are applicable to working as well as nonworking RA patients, and we perform such studies using these methods...
  23. ncbi Why the HAQ-II can be an effective substitute for the HAQ
    F Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, 1035 N Emporia, Suite 230, Wichita, KS 67214, USA
    Clin Exp Rheumatol 23:S29-30. 2005
    ..HAQ-II is better correlated with clinical measures than the HAQ and is sensitive to change. The HAQ-II is suitable for use in the clinic and research studies...
  24. ncbi A brief introduction to the National Data Bank for Rheumatic Diseases
    F Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, National Data Bank for Rheumatic Diseases, 1035 N Emporia, Suite 230, Wichita, KS 67214, USA
    Clin Exp Rheumatol 23:S168-71. 2005
    ..It has systematic, ongoing quality control programs that assure high quality data. NDB-developed programs result in very efficient analytic capabilities and rapid publication...
  25. ncbi Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients
    Frederick Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 31:2115-20. 2004
    ..We evaluate the importance of fatigue in relation to other measures of clinical status, describe predictors of fatigue, and investigate fatigue levels in patients treated with anti-TNF therapy...
  26. ncbi Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness
    F Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Wichita, KS 67214, USA
    Rheumatology (Oxford) 44:iv18-iv22. 2005
    ..The consequence of deriving effectiveness estimates from clinical trials is to overestimate the effectiveness and thereby the cost-effectiveness of rheumatoid arthritis treatments...
  27. ncbi The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas 67214, USA
    Arthritis Rheum 52:3873-9. 2005
    ....
  28. ncbi The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, KS 67214, USA
    Arthritis Rheum 56:1433-9. 2007
    ..This report updates our previous report during 29,314 person-years of followup...
  29. ncbi Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas 67214, USA
    Arthritis Rheum 56:2135-42. 2007
    ..This study was undertaken to investigate patients' acceptance and satisfaction with therapy, willingness to change therapy, and reasons for not changing...
  30. ncbi Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Wichita, Kansas 67214, USA
    J Rheumatol 34:1674-83. 2007
    ....
  31. doi Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 37:1615-25. 2010
    ..To compare the US EQ-5D with the UK EQ-5D and the SF-6D in patients with rheumatoid arthritis (RA). To provide mappings for each of the scales based on clinical variables...
  32. doi The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, 1035 N Emporia, Suite 288, Wichita, KS 67214, USA
    Rheumatology (Oxford) 50:16-24. 2011
    ....
  33. doi Mortality in fibromyalgia: a study of 8,186 patients over thirty-five years
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS 67214, USA
    Arthritis Care Res (Hoboken) 63:94-101. 2011
    ..To determine if mortality is increased among patients diagnosed as having fibromyalgia...
  34. doi The Hawthorne effect, sponsored trials, and the overestimation of treatment effectiveness
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N Emporia, Suite 288, Wichita, KS 67214, USA
    J Rheumatol 37:2216-20. 2010
    ..To determine if the results of rheumatoid arthritis (RA) clinical trials are upwardly biased by the Hawthorne effect...
  35. doi The development of fibromyalgia--I: examination of rates and predictors in patients with rheumatoid arthritis (RA)
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, KS, USA
    Pain 152:291-9. 2011
    ..After diagnosis, patients move in both directions across the diagnostic criteria cut points...
  36. doi Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N Emporia, Suite 288, Wichita, KS 67214, USA
    J Rheumatol 38:1113-22. 2011
    ..We also created a new FM symptom scale to further characterize FM severity...
  37. doi Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N Emporia, Suite 288, Wichita, KS 67214, USA
    J Rheumatol 38:1104-12. 2011
    ....
  38. doi The longitudinal outcome of fibromyalgia: a study of 1555 patients
    Brian Walitt
    National Data Bank for Rheumatic Diseases, 1035 N Emporia, Suite 288, Wichita, KS 67214, USA
    J Rheumatol 38:2238-46. 2011
    ..To describe the diagnosis status and outcome of patients diagnosed with fibromyalgia (FM) by US rheumatologists...
  39. pmc The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N, Emporia, Suite 288, Wichita, KS 67214, USA
    Arthritis Res Ther 12:R35. 2010
    ..We modeled the progression of loss of health status, and measured incremental costs and effectiveness of biologic therapy in the community...
  40. doi Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas, USA
    J Rheumatol 37:305-15. 2010
    ....
  41. doi EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas, USA
    J Rheumatol 37:296-304. 2010
    ..By contrast the Euroqol EQ-5D can be used for cost-effectiveness analyses. The EQ-5D has rarely been used in systemic lupus erythematosus (SLE). We compared SF-36 and EQ-5D values across rheumatic diseases...
  42. ncbi Rheumatoid arthritis treatment and the risk of severe interstitial lung disease
    F Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Wichita, KS 67214, USA
    Scand J Rheumatol 36:172-8. 2007
    ..Reports have suggested that infliximab with or without azathioprine might lead to rapidly progressive or fatal ILD. We used an RA data bank to assess the associations of treatments for RA and severe ILD...
  43. ncbi Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS 67214, USA
    Arthritis Rheum 56:2886-95. 2007
    ..We undertook this study to assess the risk of malignancy among biologic-treated patients in a large US observational database...
  44. ncbi The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N Emporia, Wichita, KS 67214, USA
    J Rheumatol 34:2211-7. 2007
    ..To determine the prevalence and incidence rates of work disability in rheumatoid arthritis (RA), and to determine the effect of anti-tumor necrosis factor (TNF) therapy on work disability...
  45. ncbi Prevalence, risk, and risk factors for oral and ocular dryness with particular emphasis on rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N Emporia, Suite 288, Wichita, KS 67214, USA
    J Rheumatol 35:1023-30. 2008
    ..To determine, primarily in rheumatoid arthritis (RA), the prevalence, relative risk, and risk factors for oral and ocular dryness...
  46. doi Proposed metrics for the determination of rheumatoid arthritis outcome and treatment success and failure
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N Emporia, Suite 288, Wichita, KS 67214, USA
    J Rheumatol 36:27-33. 2009
    ....
  47. doi Outcome and predictor relationships in fibromyalgia and rheumatoid arthritis: evidence concerning the continuum versus discrete disorder hypothesis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N Emporia, Suite 288, Wichita, KS 67214, USA
    J Rheumatol 36:831-6. 2009
    ..To compare outcome-predictor relationships in fibromyalgia (FM) and rheumatoid arthritis (RA), to provide information regarding the competing hypotheses that FM is a continuum or a discrete disorder...
  48. doi Remission in rheumatoid arthritis: physician and patient perspectives
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University ofKansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 36:930-3. 2009
    ....
  49. doi Out-of-pocket expenses and their burden in patients with rheumatoid arthritis
    Frederick Wolfe
    University of Kansas School of Medicine, Kansas, USA
    Arthritis Rheum 61:1563-70. 2009
    ..To describe and understand the burden of out-of-pocket expenses in patients with rheumatoid arthritis (RA)...
  50. doi Fibromyalgia diagnosis and diagnostic criteria
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas, USA
    Ann Med 43:495-502. 2011
    ..This enabled physicians who were opposed to the idea of fibromyalgia to also assess and diagnose patients using an alternative nomenclature...
  51. ncbi Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire
    Frederick Wolfe
    Arthritis Research Center Foundation, Wichita, Kansas, USA
    Arthritis Rheum 50:3296-305. 2004
    ..We undertook this study to develop and validate a revised version of the HAQ (the HAQ-II)...
  52. ncbi Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas, USA
    J Rheumatol 31:1896-902. 2004
    ....
  53. ncbi Assessing radiographic status of rheumatoid arthritis: introduction of a short erosion scale
    F Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, Kansas, USA
    J Rheumatol 27:2090-9. 2000
    ..We investigated the scoring and scaling properties of radiographs read by the Larsen method, and we developed a shortened scale that can be placed in the perspective of a linear severity continuum...
  54. ncbi Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy
    F Wolfe
    National Data Bank for Rheumatic Diseases Arthritis Research Center Foundation, Inc, Wichita, Kansas 67214, USA
    J Rheumatol 28:1712-7. 2001
    ..With the use of quantile charts, the comparative status of RA and the change in RA status can be determined easily...
  55. ncbi Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases Arthritis Research Center Foundation, Wichita, Kansas 67214, USA
    J Rheumatol 31:355-8. 2004
    ..To compare COX-2-specific inhibitor therapy with conventional nonspecific nonsteroidal antiinflammatory drugs (NS NSAID), and investigate the effect of demographic and disease factors on NSAID duration of use...
  56. ncbi Measuring the epidemiology of distress: the rheumatology distress index
    F Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Reserach Center Foundation, and University of Kansas School of Medicine, Wichita 67214, USA
    J Rheumatol 27:2000-9. 2000
    ....
  57. ncbi Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas, USA
    J Rheumatol 30:1725-32. 2003
    ..In addition, (4) we test the feasibility of performing a clinical trial using a longitudinal data bank...
  58. ncbi Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases Arthritis Research Center Foundation and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 30:369-78. 2003
    ..To develop and validate a pain scale that measures the extent of body pain...
  59. ncbi Radiographic methods in knee osteoarthritis: a further comparison of semiflexed (MTP), schuss-tunnel, and weight-bearing anteroposterior views for joint space narrowing and osteophytes
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, USA
    J Rheumatol 29:2597-601. 2002
    ..Osteophytes are also dependent on positioning. This study investigated the consequences of positioning on JSN and osteophytes in clinical studies in which the outcome of OA knee is scored...
  60. doi The challenges of determining RA disease activity and remission in clinical practice
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, and University of Kansas School of Medicine, Wichita, KS 67214, USA
    Nat Clin Pract Rheumatol 4:462-3. 2008
  61. ncbi Evaluating severity and status in rheumatoid arthritis
    F Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Inc and University of Kansas School of Medicine, Wichita, Kansas, USA
    J Rheumatol 28:1453-62. 2001
    ..Further, RCT can be evaluated as to severity status of patients participating, and the generalizability of RCT can be better evaluated...
  62. ncbi Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy
    Frederick Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita 67214, USA
    Am J Med 116:305-11. 2004
    ..We sought to determine the frequency of heart failure in patients with rheumatoid arthritis, and to determine its predictors, particularly the use of anti-tumor necrosis factor (TNF) therapy...
  63. ncbi Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Foundation, Wichita, KS 67214, USA
    Arthritis Rheum 50:1740-51. 2004
    ..Additionally, we sought to determine predictors of lymphoma in RA...
  64. ncbi Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Wichita, KS 67214, USA
    J Rheumatol 31:1143-51. 2004
    ....
  65. ncbi Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases Arthritis Research Center Foundation and University of Kansas School of Medicine, Wichita 67214, USA
    J Rheumatol 29:467-73. 2002
    ....
  66. ncbi Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 31:695-700. 2004
    ..Little is known about FM among patients with rheumatoid arthritis (RAF). We used the survey definition to characterize persons with RAF and to obtain insight into possible pathogenic mechanisms...
  67. ncbi Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas, USA
    J Rheumatol 30:36-40. 2003
    ..To determine whether the risk for cardiovascular and/or cerebrovascular disease (CCVD) is increased in rheumatoid arthritis (RA) compared to osteoarthritis (OA), a disease not known to be associated with increased CCVD...
  68. ncbi Radiography of rheumatoid arthritis in the time of increasing drug effectiveness
    F Wolfe
    Arthritis Research Center Foundation, 1035 N Emporia, Suite 230, Wichita, KS 67214, USA
    Curr Rheumatol Rep 3:46-52. 2001
    ..Interpretation of radiograph data in future trials will be aided by utilization of common reading methods and by continuing comparison across differing rheumatoid arthritis protocol populations...
  69. ncbi Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthr
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases Arthritis Research Center Foundation, and University of Kansas School of Medicine, Wichita 67214, USA
    J Rheumatol 29:1015-22. 2002
    ..Analytical methods (propensity scores) are available to mitigate the effect of nonrandom assignment if the full extent of confounding can be understood...
  70. ncbi A short history of data banking in the United States from 1974 to 2003
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation and the University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol Suppl 69:41-5. 2004
    ..Hybrid models using both survey data and clinical data were put into practice by Pincus and Wolfe, and by Paulus at the Western Consortium...
  71. ncbi The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas, USA
    Arthritis Rheum 49:59-63. 2003
    ..To assess the acceptability of self-report questionnaires (SRQ) in clinical practice and to understand the value that rheumatologists give to various assessment methods in rheumatoid arthritis...
  72. ncbi The longterm outcome of osteoarthritis: rates and predictors of joint space narrowing in symptomatic patients with knee osteoarthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, 67214, USA
    J Rheumatol 29:139-46. 2002
    ..To determine the rate of progression of radiographic joint space narrowing (JSN) and the factors that predict it in symptomatic clinic patients with knee osteoarthritis (OA)...
  73. ncbi Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior
    Esi Morgan Dewitt
    Children s Hospital of Philadelphia, and Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Arch Intern Med 166:57-63. 2006
    ....
  74. pmc Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study
    Zurab Nadareishvili
    Georgetown University Hospital, Washington, DC, USA
    Arthritis Rheum 59:1090-6. 2008
    ..To determine the risk of stroke in patients with rheumatoid arthritis (RA) and risk factors associated with stroke...
  75. doi Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity
    Frederick Wolfe
    University of Kansas School of Medicine and National Data Bank for Rheumatic Diseases, Wichita, Kansas
    Arthritis Rheum 61:667-73. 2009
    ..To determine the incidence of self-reported depression (SRD) in rheumatoid arthritis and to identify and rank clinically useful predictors of depression...
  76. ncbi The association of rheumatoid arthritis and its treatment with sinus disease
    Kaleb Michaud
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 33:2412-5. 2006
    ..To determine if rates of sinus disease are increased in patients with rheumatoid arthritis (RA) and whether RA treatment alters the risk of sinus disease...
  77. ncbi Seasonal symptom severity in patients with rheumatic diseases: a study of 1,424 patients
    D J Hawley
    National Data Bank for Rheumatic Diseases--Arthritis Research Center Foundation, Wichita, KS 67214, USA
    J Rheumatol 28:1900-9. 2001
    ..Although patients with FM and Season (+) patients report more severe symptoms, their pattern of reporting and their actual scores do not differ according to season compared to persons without FM or positive seasonality...
  78. pmc Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out
    Saralynn Allaire
    Clinical Epidemiology Research and Training Unit, Boston University, 715 Albany Street, Boston, MA 02118, USA
    Arthritis Rheum 59:1082-9. 2008
    ..To examine the role of anti-tumor necrosis factor (anti-TNF) agents in predicting work disability in subjects with rheumatoid arthritis (RA)...
  79. ncbi Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients
    Kaleb Michaud
    Arthritis Research Center Foundation, Wichita, Kansas, USA
    Arthritis Rheum 48:2750-62. 2003
    ..To estimate total direct medical costs in persons with rheumatoid arthritis (RA) and to characterize predictors of these costs...
  80. ncbi The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis
    Olivier Ethgen
    Department of Public Health and Epidemiology, University of Liege, Belgium
    J Rheumatol 29:1147-55. 2002
    ..We evaluated the impact of health related quality of life (HRQL) on future HCRU in patients with arthritis...
  81. ncbi Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA
    J Rheumatol 32:2130-5. 2005
    ....
  82. ncbi Gastrointestinal prophylactic therapy among patients with arthritis treated by rheumatology specialists
    Elizabeth Benito Garcia
    Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Rheumatol 33:779-84. 2006
    ..To determine rates of gastroprotective agent (GPA) use among patients with arthritis treated by rheumatologists, and to determine factors associated with GPA prescription...
  83. ncbi Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology
    F Wolfe
    University of Kansas School of Medicine, Wichita, USA
    J Rheumatol 26:484-9. 1999
    ..The core set is intended to serve as a core for LOS in almost all rheumatic conditions...
  84. ncbi Severity of joint pain and Kellgren-Lawrence grade at baseline are better predictors of joint space narrowing than bone scintigraphy in obese women with knee osteoarthritis
    Steven A Mazzuca
    Department of Medicine, Indiana University School of Medicine IUSM, Indianapolis, 46202, USA
    J Rheumatol 32:1540-6. 2005
    ....
  85. ncbi Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
    Daniel O Clegg
    Division of Rheumatology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    N Engl J Med 354:795-808. 2006
    ..The multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) evaluated their efficacy and safety as a treatment for knee pain from osteoarthritis...
  86. ncbi Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients
    Nancy Walker
    Rheumatology Division, Department of Medicine, University of Massachusetts, Worcester, Massachusett, USA
    J Rheumatol 32:1006-12. 2005
    ..To describe workplace limitations and the validity and reliability of the Work Limitations Questionnaire (WLQ) in persons with rheumatoid arthritis (RA)...
  87. ncbi Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis
    Dennis C Ang
    Division of Rheumatology, Indiana University School of Medicine, Indianapolis, Indiana, USA
    J Rheumatol 32:1013-9. 2005
    ..Whether comorbid depression increases mortality in patients with rheumatoid arthritis (RA) is unknown. Our objective was to determine whether the presence of depression predicted mortality in patients with RA...
  88. ncbi Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: standards of practice for RA treatment
    F Wolfe
    National Data Bank for Rheumatic Diseases Arthritis Research Center Foundation, Inc, Wichita, Kansas 67214, USA
    J Rheumatol 28:1704-11. 2001
    ..The standard may at times be in conflict with the goals of insurers, but there is no legitimate medical reason for such limitations...
  89. ncbi The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course of the illness
    F Wolfe
    National Data Bank for Rheumatic Disease Arthritis Research Center Foundation, Wichita, Kansas 67214, USA
    J Rheumatol 28:1817-24. 2001
    ....
  90. ncbi Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS 67214, USA
    Arthritis Care Res (Hoboken) 62:775-84. 2010
    ..We have studied the largest unselected series of patients to date to evaluate the risk of toxicity and the relevance of purported risk factors...
  91. pmc Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N Emporia, Suite 288, Wichita, KS 67214, USA
    J Rheumatol 36:82-8. 2009
    ....
  92. doi The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS 67214, USA
    Arthritis Care Res (Hoboken) 62:600-10. 2010
    ....
  93. doi The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas, and University of Kansas School of Medicine, Wichita, KS 67214, USA
    Arthritis Rheum 58:2612-21. 2008
    ....
  94. ncbi Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas 67214, USA
    Arthritis Rheum 57:935-42. 2007
    ....
  95. ncbi Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas, and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    Arthritis Rheum 50:372-9. 2004
    ..We undertook this study to determine the baseline rate of TB in RA prior to the introduction of infliximab and to determine the rate of TB among those currently receiving infliximab...
  96. ncbi Predicting mortality in patients with rheumatoid arthritis
    Frederick Wolfe
    Arthritis Research Center Foundation and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    Arthritis Rheum 48:1530-42. 2003
    ..This study was undertaken to evaluate the relative predictive strength and usefulness of a wide range of variables on the risk of mortality in a large, long-term, prospectively studied cohort of patients with RA...
  97. ncbi Patient questionnaires for clinical research and improved standard patient care: is it better to have 80% of the information in 100% of patients or 100% of the information in 5% of patients?
    Theodore Pincus
    J Rheumatol 32:575-7. 2005
  98. ncbi Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model
    Frederick Wolfe
    J Rheumatol 31:2317-9. 2004
  99. ncbi The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitors
    Elizabeth Benito-Garcia
    Department of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Rheumatol 34:1765-9. 2007
    ....
  100. ncbi HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias
    James F Fries
    Stanford University School of Medicine, Palo Alto, California, USA
    Arthritis Rheum 46:2320-9. 2002
    ..The present study was undertaken to study these issues in a large cohort of patients with RA...
  101. ncbi Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia
    F Wolfe
    Arthritis Research Center and University of Kansas School of Medicine, Wichita 67214, USA
    Arthritis Rheum 43:378-85. 2000
    ....